
Vamstar transforms the Lifescience industry by leveraging agentic AI for commercial success in tendering, pricing, market access, and contracts. Their solutions are purpose-built for MedTech, Pharma, and Biotech teams, trained on real-world data and embedded in workflows to deliver measurable margin impact. Vamstar offers a core solution called Polaris, which maximizes operational efficiency through advanced data science and AI for tendering, pricing, and market access, including tender and RFx matching, price optimization, value analysis, and VBP/ESG tracking. The company's impact is demonstrated by a 92% improvement in data intelligence coverage, a 20x improvement in operating environment, and a 7.5% improvement in margin profile for organizations.

Vamstar transforms the Lifescience industry by leveraging agentic AI for commercial success in tendering, pricing, market access, and contracts. Their solutions are purpose-built for MedTech, Pharma, and Biotech teams, trained on real-world data and embedded in workflows to deliver measurable margin impact. Vamstar offers a core solution called Polaris, which maximizes operational efficiency through advanced data science and AI for tendering, pricing, and market access, including tender and RFx matching, price optimization, value analysis, and VBP/ESG tracking. The company's impact is demonstrated by a 92% improvement in data intelligence coverage, a 20x improvement in operating environment, and a 7.5% improvement in margin profile for organizations.
Founded: 2019
Core product: Polaris — agentic AI platform for tendering, pricing, market access and contracts
Industry: MedTech / Pharma / Life Sciences (Hospitals and Health Care)
Headquarters: London, United Kingdom
Recent funding: Series A (Jun 22, 2022)
Commercialisation and procurement in life sciences — tendering, RFx automation, pricing and market access
2019
Hospitals and Health Care
approximately $9.5M reported by some profiles
Series A reported on Jun 22, 2022; total raised across rounds reported variably (e.g., $11.2M on some databases).
“Backed by venture investors including Alpha Intelligence Capital, b2venture, Begin Capital and Antler”
| Company |
|---|